FINWIRES · TerminalLIVE
FINWIRES

Takeda Pharmaceutical Insider Sold Shares Worth $1,523,439, According to a Recent SEC Filing

By

Julie So-Young Kim, Director, President and Chief Executive Officer, on August 10, 2026, sold 89,090 shares in Takeda Pharmaceutical (TAK) for $1,523,439. Following the Form 4 filing with the SEC, Kim has control over a total of 391,489 American depositary shares of the company, with 391,489 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1395064/000149315226037484/xslF345X05/ownership.xml

Related Articles